PT  - JOURNAL ARTICLE
AU  - Masuda, Jun
AU  - Sakai, Hitomi
AU  - Tsurutani, Junji
AU  - Tanabe, Yuko
AU  - Masuda, Norikazu
AU  - Iwasa, Tsutomu
AU  - Takahashi, Masato
AU  - Futamura, Manabu
AU  - Matsumoto, Koji
AU  - Aogi, Kenjiro
AU  - Iwata, Hiroji
AU  - Hosonaga, Mari
AU  - Mukohara, Toru
AU  - Yoshimura, Kiyoshi
AU  - Imamura, Chiyo K
AU  - Miura, Sakiko
AU  - Yamochi, Toshiko
AU  - Kawabata, Hidetaka
AU  - Yasojima, Hiroyuki
AU  - Tomioka, Nobumoto
AU  - Yoshimura, Kenichi
AU  - Takano, Toshimi
TI  - Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
AID  - 10.1136/jitc-2023-007126
DP  - 2023 Sep 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e007126
VI  - 11
IP  - 9
4099  - http://jitc.bmj.com/content/11/9/e007126.short
4100  - http://jitc.bmj.com/content/11/9/e007126.full
SO  - J Immunother Cancer2023 Sep 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.